The Novel Conduit: Challenges of Esophagectomy After Bariatric Surgery

Metabolic surgery has been on the rise over the last 2 decades. As more literature has been being published regarding its efficacy in treating metabolic syndrome as well as advancements in surgical training and safety rise with it, metabolic surgery will in no doubt continue to increase in prevalenc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal surgery 2023-04, Vol.27 (4), p.653-657
Main Authors: Jureller, Michael, Logarajah, Shankar I., Van Meter, Travis Allen, Osman, Housam, Jay, John, Moslim, Maitham, Aye, Ralph, Jeyarajah, D. Rohan
Format: Article
Language:English
Subjects:
Bariatric Surgery - adverse effects
Biopsy
Colon
Colon - transplantation
Colonoscopy
Endoscopy
Esophageal cancer
Esophageal Neoplasms - surgery
Esophagectomy - adverse effects
Esophagectomy - methods
Gastroenterology
Gastrointestinal surgery
Humans
Laparoscopy
Medicine
Medicine & Public Health
Metabolism
Ostomy
Pathology
Patients
SSAT Paper
Stomach
Surgery
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic surgery has been on the rise over the last 2 decades. As more literature has been being published regarding its efficacy in treating metabolic syndrome as well as advancements in surgical training and safety rise with it, metabolic surgery will in no doubt continue to increase in prevalence. Concomitantly, the prevalence of esophageal cancer is increasing. We present two cases of patients who are status post sleeve gastrectomy and require esophagectomy. These patients do not have the availability of a gastric conduit, and colon interposition graft was planned for their reconstructions. We here review the two unique case scenarios as well as an overview of colon interposition technique and workup considerations. The need this reconstruction technique will likely increase in the years to come and metabolic surgery and esophageal cancer both continue to rise.
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-022-05378-x